April 19: First Annual Wisconsin Stem Cell Symposium

The First Annual Wisconsin Stem Cell Symposium will be held April 19, 2006 at the BioPharmaceutical Technology Center (BTC), 5445 East Cheryl Parkway, Madison, WI.

Focusing on neural stem cells and the brain: This symposium brings together some of the leading researchers interested in how stem cells produce neurons and other types of cells found in the brain. Our
understanding of this process may provide important information for the future treatment of neurological illnesses such as Parkinson’s disease, Multiple Sclerosis and ALS. Highlighted issues are:

• Human embryonic stem cells and neuronal production

• The mechanisms of neural stem cell fate choices

• The importance of adult neural stem cells in health and disease

• Using stem cells to deliver drugs to the brain


Link for more information.


April 20 and 21: Fifth Annual International Bioethics Forum: Clones and Chimeras

The Fifth Annual International Bioethics Forum: Clones and Chimeras which will be held April 20-21, 2006 at the BioPharmaceutical Technology Center (BTC), 5445 East Cheryl Parkway, Madison, WI.

The Forum has been approved for 12 WI CLE credits.


Focusing on the interface between molecular biology, medical applications and ethics, keynote presentations and break-out sessions are designed to facilitate participants’ understanding of:

• Current scientific research that utilizes uses chimeras or clones

• Ethical issues related to this research and its potential applications

• The diversity of viewpoints regarding these issues

• The complexities involved in both the scientific and ethical dimensions of these topics


Link for more information.


USPTO to hold Open Source Software Community Meeting February 16, 2006

USPTO to hold Open Source Software Community Meeting February 16, 2006

The Department of Commerce’s United States Patent and Trademark Office (USPTO) has created a partnership with the open source community to ensure that patent examiners have improved access to all available prior art relating to software code during the patent examination process.

Link to more information.


Cultural considerations are increasingly vital in multidisciplinary research

CONTACT: Carol Ryff (608) 262-9772, cryff@wisc.edu

PSYCHOLOGIST: MAKE CULTURE PART OF THE NEW COLLABORATIVE SCIENCE

MADISON-Cultural considerations are increasingly vital in multidisciplinary research as more scientists stray from narrowly focused studies to expansive, boundary-blurring questions, a University of Wisconsin-Madison psychologist will announce to attendees (May 27) at the 17th Annual Convention of the American Psychology Society in Los Angeles.

Academic fields are rapidly converging to form emerging hybrids with tongue-twisting names such as psychoneuroimmunology. But, Ryff says, integrative work cannot tell the whole story - or hope to create tailored, individualized interventions - unless researchers pay heed to the broader cultural context of their work.

Continue reading "Cultural considerations are increasingly vital in multidisciplinary research" »


THE (STRONG NUCLEAR) FORCE TO BE WITH PHYSICISTS CONVERGING ON MADISON

THE (STRONG NUCLEAR) FORCE TO BE WITH PHYSICISTS CONVERGING ON MADISON

MADISON - Physicists from around the world will gather at Madison's Monona Terrace later this month (April 27-May 1) to explore the world of quarks - subatomic particles that represent the frontier of modern particle physics.

The meeting, which organizers believe may draw as many 250 particle physicists, will focus on the "strong nuclear force," a field also known as quantum chromodynamics, according to meeting organizer and UW-Madison physics Professor Wesley H. Smith.

At one time, scientists thought atoms were the smallest of nature's building blocks. It has only been in the past century that physicists realized that atoms are made up of even smaller particles, neutrons, protons and electrons. In the 1960s and 1970s, scientists discovered signs of internal structure within protons and neutrons, suggesting that these subatomic particles are composed of quarks and the gluons that bind them together.

Continue reading "THE (STRONG NUCLEAR) FORCE TO BE WITH PHYSICISTS CONVERGING ON MADISON" »


BTCI's Fourth Annual International Bioethics Forum to Focus on Biotechnology and the Brain

Fourth Annual International Bioethics Forum
Biotechnology and the Brain: From Therapy to Enhancement
April 21-22, 2005; BioPharmaceutical Technology Center Institute, Madison, WI

Focusing on the interface between neuroscience, molecular biology, medical applications and ethics, keynote presentations and concurrent sessions are designed to facilitate participants’ understanding of:
•Current scientific research related to neurological disorders
• Ethical issues related to this research and its potential applications
• The diversity of viewpoints regarding these issues
• The complexities involved in both the scientific and ethical dimensions of these topics

Link for more information.


MCW requests $25Million for Biomedical Research and Technology Incubator Facility

State of Wisconsin
Higher Education Subcommittee Hearing

Wednesday, November 17, 2004
10:30 a.m.
Room 201 South East
State Capitol
. . .

10. Medical College of Wisconsin (Milwaukee) – Request
release of $25,000,000 General Fund Supported
Borrowing to assist in the development and
construction of a Biomedical Research and
Technology Incubator Facility at a total estimated
project cost of $132,000,000.
Commitment for the state funds will be in the form of
a construction grant.
The grant was enumerated in 2001 Wisconsin Act 16.

Full document.


The selling of science

The selling of science
10:58 pm 11/13/04
Judy Newman Wisconsin State Journal

Leaders of 33 young technology companies are practicing their pitches as they prepare for the Wisconsin Life Sciences & Venture Conference in Madison on Tuesday and Wednesday.

Traditionally, it's a chance to show potential investors some of the area's brightest discoveries with the best prospects for success in the marketplace.

Companies with products aimed at curing cancer, preventing strokes and identifying malignant breast tumors are among those that will try to persuade venture capitalists and other early-stage backers, sometimes called angel investors, to put money into their technology.

And this year, organizers have tied in a second-day program showcasing some of the promising research at UW- Madison that's not yet ready for the marketplace.

Full story.